- Home
- ABAT vs ALEC Comparison
ABAT vs ALEC Comparison
Compare ABAT & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABAT
- ALEC
- Stock Information
- Founded
- ABAT 2011
- ALEC 2013
- Country
- ABAT United States
- ALEC United States
- Employees
- ABAT N/A
- ALEC N/A
- Industry
- ABAT Metal Mining
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ABAT Basic Materials
- ALEC Health Care
- Exchange
- ABAT Nasdaq
- ALEC Nasdaq
- Market Cap
- ABAT 87.2M
- ALEC 101.1M
- IPO Year
- ABAT N/A
- ALEC 2019
- Fundamental
- Price
- ABAT $1.40
- ALEC $1.17
- Analyst Decision
- ABAT
- ALEC Buy
- Analyst Count
- ABAT 0
- ALEC 7
- Target Price
- ABAT N/A
- ALEC $4.70
- AVG Volume (30 Days)
- ABAT 2.0M
- ALEC 928.9K
- Earning Date
- ABAT 05-19-2025
- ALEC 05-08-2025
- Dividend Yield
- ABAT N/A
- ALEC N/A
- EPS Growth
- ABAT N/A
- ALEC N/A
- EPS
- ABAT N/A
- ALEC N/A
- Revenue
- ABAT $877,900.00
- ALEC $88,339,000.00
- Revenue This Year
- ABAT $31,748.62
- ALEC N/A
- Revenue Next Year
- ABAT N/A
- ALEC $376.51
- P/E Ratio
- ABAT N/A
- ALEC N/A
- Revenue Growth
- ABAT N/A
- ALEC N/A
- 52 Week Low
- ABAT $0.73
- ALEC $0.87
- 52 Week High
- ABAT $4.11
- ALEC $6.78
- Technical
- Relative Strength Index (RSI)
- ABAT 57.02
- ALEC 51.49
- Support Level
- ABAT $1.30
- ALEC $0.97
- Resistance Level
- ABAT $1.46
- ALEC $1.34
- Average True Range (ATR)
- ABAT 0.16
- ALEC 0.11
- MACD
- ABAT 0.01
- ALEC 0.01
- Stochastic Oscillator
- ABAT 47.14
- ALEC 53.68
About ABAT American Battery Technology Company
American Battery Technology Co is engaged in lithium-ion battery recycling, battery metals and material extraction, and resource production. It is a battery metals company producing low-cost battery metals with a commitment to closed-loop, clean energy technologies.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.